ACR GUIDELINES Bundle (free trial)

Juvenile Idiopathic Arthritis - Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis and Systemic JIA

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512423

Contents of this Issue

Navigation

Page 11 of 13

12 Treatment Figure 3. Treatment for Systemic JIA Systemic JIA NO YES Continue treatment and monitor Alternative IL-1 or IL-6 inhibitor (no preferred agent) Presence of MAS Residual arthritis? Inactive systemic JIA? Incomplete response or intolerance? NO YES IL-1 or IL-6 inhibitor monotherapy (no preferred agent) Brief trial of scheduled NSAIDs and/or NO YES YES YES Taper and stop biologic DMARDs Continue treatment and monitor Not on GCs NO

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Juvenile Idiopathic Arthritis - Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis and Systemic JIA